Doppler US in rheumatic diseases with special emphasis on rheumatoid arthritis and spondyloarthritis

Por Toprak, Hüseyin, Kılıç, Erkan, Serter, Aslı, Kocakoç, Ercan, Özgöçmen, Salih
Publicado no Diagn Interv Radiol (2014)

Differential requirements for induction of total immunoglobulin and physiological rheumatoid factor production by human peripheral blood B cells

Por Van esch, W J. E, Reparon-Schuijt, C C, Levarht, E W. N, Van kooten, C, BreedveLd, F C, Verweij, C L
Publicado em 2001

Orthopaedic surgeries in rheumatic patient

Por Moises Cohen, Mário Ferretti, Frank Beretta Marcondes
Publicado em 2008-03-01

Different regulation of factor H and FHL-1/reconectin by inflammatory mediators and expression of the two proteins in rheumatoid arthritis (RA)

Por Friese, M A, Hellwage, J, Jokiranta, T S, Meri, S, Müller-Quernheim, H J, Peter, H H, Eibel, H, Zipfel, P F
Publicado em 2000

Down-regulation of the T cell receptor CD3ζ chain in rheumatoid arthritis (RA) and its influence on T cell responsiveness

Por Berg, L, Rönnelid, J, Klareskog, L, Bucht, A
Publicado em 2000

KONSUPREN IN THETHERAPY OF RHEUMATIC DISEASES

Por Z S Alekberova, N. S.V. Shekshina, A. V. Elonakov, V A Nassonova, Z S Alekberova
Publicado em 2001-04-01

HEMOLYTIC ASSAY OF THE NINTH COMPLEMENT COMPONENT: ELEVATION AND DEPLETION IN RHEUMATIC DISEASES

Por Ruddy, Shaun, Everson, Lloyd K., Schur, Peter H., Austen, K. Frank
Publicado em 1971

Post covid syndrome and rheumatic diseases: focus on rheumatoid arthritis (own data)

Por E. S. Aronova, B. S. Belov, G. I. Gridneva
Publicado em 2022-03-01

A short history of anti-rheumatic therapy - VI. Rheumatoid arthritis drugs

Por G. Pasero, P. Marson
Publicado em 2011-09-01

SKIN REACTIONS TO NUCLEOPROTEIN OF STREPTOCOCCUS SCARLATINAE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND RHEUMATIC FEVER

Por Myers, Walter K., Keefer, Chester S., Oppel, Theodore W.
Publicado em 1933

Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis

Por Koch, Alisa E, Distler, Oliver
Publicado em 2007

Predictors of Stopping and Starting Disease Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis

Por Solomon, Daniel H., Tonner, Chris, Lu, Bing, Kim, Seoyoung C, Ayanian, John Z., Brookhart, M. Alan, Katz, Jeffrey N., Yelin, Ed
Publicado em 2014

CLINICAL SIGNIFICANCE OF CALPROTECTIN IN RHEUMATIC DISEASES

Por A. S. Avdeeva
Publicado em 2018-09-01

Sulfasalazine efficacy and tolerability in rheumatic diseases

Por V. V. Badokin
Publicado em 2005-08-01

Rheumatic pain management: molecular aspects

Por E. V. Chetina, E. P. Sharapova
Publicado em 2020-03-01

Tumour necrosis factor-alpha (TNF-α) enhances lymphocyte migration into rheumatoid synovial tissue...

Por Wahid, S, Blades, M C, De Lord, D, Brown, I, Blake, G, Yanni, G, Haskard, D O, Panayi, G S, Pitzalis, C
Publicado em 2000

Nimulid efficacy and tolerability in patients with rheumatic diseases

Por R M Balabanova, T P Grishaeva, O V Siepaneis
Publicado em 2004-02-01

Mini-Review: Human Microbiome and Rheumatic Diseases

Por Meltem Vural, Benoit Gilbert, Işıl Üstün, Sibel Caglar, Axel Finckh
Publicado em 2020-11-01

CHARACTERISTICS OF RHEUMATIC PATHOLOGY IN THE REPUBLIC OF TAJIKISTAN AS DEFINED IN HOSPITAL

Por S. M. Shukurova, M. F. Akhunova, M. F. Abdullayev, Z. D. Khamroyeva, G. N. Karimova
Publicado em 2014-10-01

Selective recruitment of CCR6-expressing cells by increased production of MIP-3α in rheumatoid arthritis

Por Matsui, T, Akahoshi, T, Namai, R, Hashimoto, A, Kurihara, Y, Rana, M, Nishimura, A, Endo, H, Kitasato, H, Kawai, S, Takagishi, K, Kondo, H
Publicado em 2001